The DCGI’s approval was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) The DCGI chief addressing …
vaccine
-
- News
COVID vaccine to be taken 28 days apart, antibodies will develop 2 weeks after last dose: AIIMS Director
As India gears up for the world`s largest vaccination programme, the Ministry of Health and Family Welfare addressed apprehensions expressed by the public regarding the COVID-19 vaccine`s effectiveness, safety and …
-
Hyderabad: City-based Bharat Biotech on Sunday described the permission for emergency use of Covaxin, the company’s homegrown vaccine for Covid-19, as a “giant leap for innovation and novel product development …
-
The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country’s first DNA vaccine candidate against COVID-19 being developed by Zydus Cadila, the Department of …
-
AMMAN: Jordan has struck a deal with Pfizer and partner BioNTech to buy 1 million doses of their COVID-19 vaccine and another 2 million doses from the World Health Organization’s …
-
The World Health Organisation on Sunday welcomed India’s decision of giving emergency use authorisation to Covid-19 vaccines, saying it will help “intensify” and “strengthen” its fight against the ongoing pandemic. …
-
Prime Minister Narendra Modi on Sunday congratulated India and it’s hard working scientists and innovators minutes after the DCGI granted approval to the vaccines against COVID-19 manufactured by Serum Institute …
-
Prime Minister Narendra Modi on Sunday lauded scientists of the country after the Drug Controller General of India (DCGI) gave approval to Serum Institute of India’s ‘Covishield’ vaccine and Bharat …
-
Home » Website » International » Watch: Vaccine Appointment Turns Into Surprise Proposal For US Healthcare Worker Outlook Web Bureau 2021-01-03T14:47:19+05:30 Watch: Vaccine Appointment Turns Into Surprise Proposal For US …
-
Hyderabad: Bharat Biotech has successfully recruited 23,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for Phase-3 clinical trial of its COVID-19 vaccine Covaxin across multiple sites …
-
Senior Congress leader Anand Sharma on Sunday raised concerns over India’s drugs regulator granting permission for restricted use of Bharat Biotech’s COVID-19 vaccine and asked the government to explain why …
-
Serum Institute of India (SII) on Sunday said it is ready to roll out Covishield vaccine in the country in the coming weeks after receiving approval from the Indian drug …
-
NEW DELHI — India on Sunday approved two coronavirus vaccines, one made by AstraZeneca and Oxford University and the other developed in India, for emergency use, a major step toward …
-
Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca COVID-19 vaccine ‘Covishield’ is ready to roll out in the coming weeks. Poonawalla’s remarks came soon after the …
- News
Coronavirus News LIVE Updates: Narendra Modi hails DCGI’s vaccine approvals as ‘turning point’ in fight against COVID-19 – India News , Firstpost
Coronavirus News LIVE Updates: Prime Minister Narendra Modi called DCGI’s emergency approval for 2 vaccines in India a “decisive turning point” in the country’s fight against the virus and expressed …
- News
Coronavirus live: India’s drugs regulator approves Oxford’s COVID-19 vaccine ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ for restricted emergency use
India has approved two COVID-19 vaccines — Serum Institute of India’s ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ — for emergency restricted use, regulatory body DCGI said on Sunday. Both vaccines have …
-
India’s drugs regulator is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally-developed one by Bharat Biotech, each four weeks apart, a Reuters report said on …
-
Scientists have slammed the new guidance which allows for the interchange of vaccines, if the second dose of the vaccine originally received is not available, saying officials have abandoned science …
-
India’s drugs regulator on Saturday recommended for emergency use a locally developed coronavirus vaccine called COVAXIN, which is expected to be a backup to the AstraZeneca/Oxford shot. COVAXIN has been …
-
Union Minister Prakash Javadekar on Saturday said that Indian government had approved emergency use of AstraZeneca/ Oxford University coronavirus vaccine, also known as Covishield in India. The minister said that …
-
Amid the dry run of coronavirus vaccine taking place in the country, Samajwadi Party (SP) chief Akhilesh Yadav on Saturday said that he will not get vaccinated against coronavirus for …
-
Samajwadi Party chief and former Uttar Pradesh chief minister Akhilesh Yadav has said that he would not take the Covid vaccine shot approved by Indian government’s expert panel, calling it …
-
After Samajwadi Party chief Akhilesh Yadav on Saturday said that he would not get a vaccine shot against coronavirus since it was a “BJP vaccine”, Uttar Pradesh Deputy Chief Minister …
-
About two million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle of January in the United Kingdom, The …
-
Following accounts of potential allergies to the Covid-19 vaccines produced by Pfizer-BioNTech and Moderna, scientists have outlined steps on safely receiving the second dose of the therapeutic in individuals who …
-
Maharashtra concluded a dry run of vaccination on over 300 people on Saturday in 12 vaccination centres across four districts. State officials said the procedure ran smoothly except for an …